Gut microbiota in patients receiving dialysis: Mechanisms, complications and the road to personalized microbiome‑based care (Review)

Gut dysbiosis is increasingly recognized as a potential contributor to poor outcomes in patients receiving dialysis, yet its mechanistic complexity and therapeutic implications remain incompletely understood in clinical practice.The uremic environment, dietary restrictions, polypharmacy and dialysis modality-specific factors collectively reshape the gut microbial ecology, promoting the overproduction of deleterious metabolites such as indoxyl sulfate, p-cresyl sulfate and trimethylamine n-oxide while depleting protective short-chain fatty acids.These alterations compromise intestinal barrier integrity, fuel systemic inflammation through endotoxemia and NOD-like receptor family pyrin domain containing 3 inflammasome activation and have been associated with cardiovascular disease, immune dysfunction, peritonitis, protein-energy wasting and cognitive impairment.although probiotic, prebiotic, synbiotic and dietary interventions show promise, heterogeneous responses across trials underscore the inadequacy of one-size-fits-all strategies.Multi-omics profiling has revealed substantial interindividual variability in microbial composition and metabolic capacity, providing a rationale for personalized approaches.The present review synthesizes current evidence on the mechanisms underlying dysbiosis and complications in patients receiving dialysis and proposes a roadmap toward personalized microbiome-based care to improve clinical outcomes.Contents 1. introduction 2. Drivers and landscape of gut dysbiosis in dialysis 3. Pathophysiological mechanisms linking gut dysbiosis to systemic complications 4. Major complications associated with gut dysbiosis in dialysis 5. Therapeutic modulation of the gut microbiome in dialysis: current evidence 6. Multi-omics approaches to characterizing dysbiosis in dialysis 7. Toward personalized microbiome-based care in dialysis 8. Future perspectives 9. conclusions

Authors

Institutions

Publication Details

Journal
Molecular Medicine Reports
Published
2026-10-15
DOI
https://doi.org/10.3892/mmr.2026.14044
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gut microbiota in patients receiving dialysis: Mechanisms, complications and the road to personalized microbiome‑based care (Review)

Chenxia Jin, Yanping Wang
Molecular Medicine Reports
Gut microbiota and health
article

Gut microbiota in patients receiving dialysis: Mechanisms, complications and the road to personalized microbiome‑based care (Review)

Chenxia Jin, Yanping Wang
article en

Abstract

Gut dysbiosis is increasingly recognized as a potential contributor to poor outcomes in patients receiving dialysis, yet its mechanistic complexity and therapeutic implications remain incompletely understood in clinical practice.The uremic environment, dietary restrictions, polypharmacy and dialysis modality-specific factors collectively reshape the gut microbial ecology, promoting the overproduction of deleterious metabolites such as indoxyl sulfate, p-cresyl sulfate and trimethylamine n-oxide while depleting protective short-chain fatty acids.These alterations compromise intestinal barrier integrity, fuel systemic inflammation through endotoxemia and NOD-like receptor family pyrin domain containing 3 inflammasome activation and have been associated with cardiovascular disease, immune dysfunction, peritonitis, protein-energy wasting and cognitive impairment.although probiotic, prebiotic, synbiotic and dietary interventions show promise, heterogeneous responses across trials underscore the inadequacy of one-size-fits-all strategies.Multi-omics profiling has revealed substantial interindividual variability in microbial composition and metabolic capacity, providing a rationale for personalized approaches.The present review synthesizes current evidence on the mechanisms underlying dysbiosis and complications in patients receiving dialysis and proposes a roadmap toward personalized microbiome-based care to improve clinical outcomes.Contents 1. introduction 2. Drivers and landscape of gut dysbiosis in dialysis 3. Pathophysiological mechanisms linking gut dysbiosis to systemic complications 4. Major complications associated with gut dysbiosis in dialysis 5. Therapeutic modulation of the gut microbiome in dialysis: current evidence 6. Multi-omics approaches to characterizing dysbiosis in dialysis 7. Toward personalized microbiome-based care in dialysis 8. Future perspectives 9. conclusions

Molecular Medicine ReportsVol. 34(6)
Gansu University of Traditional Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 24%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.